| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRVA | Common Stock, $0.01 par value per share | Options Exercise | $41.6K | +20.8K | +21.34% | $2.00* | 118K | May 1, 2023 | Direct | |
| transaction | PRVA | Common Stock, $0.01 par value per share | Sale | -$583K | -20.8K | -17.59% | $28.03 | 97.4K | May 1, 2023 | Direct | F1, F2 |
| transaction | PRVA | Common Stock, $0.01 par value per share | Sale | -$208K | -7.54K | -7.74% | $27.58 | 89.9K | May 1, 2023 | Direct | F3, F4 |
| transaction | PRVA | Common Stock, $0.01 par value per share | Sale | -$208K | -7.63K | -8.49% | $27.26 | 82.2K | May 2, 2023 | Direct | F5, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRVA | Stock Option (Right to Purchase) | Options Exercise | $0 | -11.7K | -25.19% | $0.00 | 34.7K | May 1, 2023 | Common Stock | 11.7K | $2.00 | Direct | F7 |
| transaction | PRVA | Stock Option (Right to Purchase) | Options Exercise | $0 | -9.09K | -4.6% | $0.00 | 189K | May 1, 2023 | Common Stock | 9.09K | $2.00 | Direct | F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale of 20,786 shares reported in this row were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.16 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F3 | The sale of 7,537 shares reported in this row represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to a "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $27.29 to $27.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F5 | The sale of 7,625 shares reported in this row represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to a "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. |
| F6 | The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $26.95 to $27.87 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| F7 | All stock options are fully vested and exercisable. |